New Delhi: Ceiling prices stand fixed for 935 scheduled formulations and the average price reduction due to the refixation of prices under the NLEM, 2022 was about 17%, leading to annual total savings of around Rs 3,802 crore to the public, the parliament was informed.

During a recent Rajya Sabha session, MP Sant Balbir Singh questioned about the rising concerns of overpricing, unethical trade practices, and the burden placed on patients by private hospitals and manufacturers. Responding to the query, the Government detailed a series of major price-control interventions implemented over the past five years to protect consumers from inflated drug costs.

Minister of State for Chemicals and Fertilizers Anupriya Patel outlined that the National Pharmaceutical Pricing Authority (NPPA) fixed

See Full Page